Skip to main content
Canna~Fangled Abstracts

Synthesis and antitumor activity of cannabigerol

By June 16, 1996May 13th, 2019No Comments

June 1996, Volume 19, Issue 3, pp 228–230

Authors

  • Seung-Hwa Baek, Seok Du Han, Chan Nam Yook, Young Chae Kim, Jung Suk Kwak

Authors and affiliations

Seung-Hwa Baek

  • Seok Du Han1
  • Chan Nam Yook2

Young Chae Kim

Jung Suk Kwak

 1.

Department of Chemistry and Department of Oral AnatomyWonkwang UniversityIksanKorea

2.

Department of Health HygienicWonkwang Public Health Junior CollegeIksanKorea

6 Citations

Abstract

Cannabigerol(3) was synthesized and evaluated for its inhibitory activity against mouse skin melanoma cells. Cannabigerol displayed significant antitumor activity [inhibitory concentration (IC50)=31.3l μ/mL]in vitro assay.

Key words

Cannabigerol, Antitumor activity, Mouse, skin, melanoma cell

Preview

References Cited

  1. Baek, S. H., Yook, C. N. and Han, D. S.: Boron trifluoride etherate on alumina-A modified Lewis acid reagent(V). A convenient single step synthesis of cannabinoids.Bull. Kor. Chem. Soc. 16(3), 293–296 (1991).Google Scholar
  2. Baek, S. H., Srebnik, M., and Mechoulam, R.: Boron trifluoride etherate on alumina-A modified Lewis acid reagent. An improved synthesis of cannabidiol.Tetrahedron Lett.26(8), 1083–1086 (1985).CrossRefGoogle Scholar
  3. Baik, K. U., and Ahn, B. Z.: Cyctotoxic activities of some geranylated flavones against L 1210 cell.J. Pharm. Soc. Korea, 32(2), 125–128 (1988).Google Scholar
  4. colasanti, B. K., and Gong, H., Marihuana 87, Chesher, G.; Consroe, P.; Musty, R. Ed., Australian Government Publishing Service, Canberra, pp. 119–124 (1988).Google Scholar
  5. Carmichael, J., Degraff, W. G., Gazdar, A. F., Minna, J. D., and Mitchell, J. B., Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing.Cancer Res. 47, 936–942 (1987).PubMedGoogle Scholar
  6. Dewey, W. L.: Cannabinoid pharmacology.Pharmacol. Rev., 38, 151–178 (1986).PubMedGoogle Scholar
  7. Kleinman, S., Weitzman, S. A., Cassem, N., and Andrews, E.: Double blind trial of δ-9-tetrahydrocannabinol (THC) as an adjunct to prochlorperazine for chemotherapy-induced vomiting.Curr. Ther. Res. 34, 1014–1017 (1983).Google Scholar
  8. Kang, K. S., Ryu, S. H., and Ahn, B. Z.: Antineoplastic natural products and the analogues VI.Arch. Pharm. Res. 8, 187–190 (1985).CrossRefGoogle Scholar
  9. Mechoulam, R.: In Cannabinoids as therapeutic agents, Boca Raton, CRC Press Inc., (1986).Google Scholar
  10. Mosmann, T. J.:Rapid colorimetric assays for cellular growth and survival: application to proliferation and cytotoxicity assays.Immunol. Methods, 65, 55–63 (1983).CrossRefGoogle Scholar
  11. McCabe, M., Smith, F. P., Macdonald, J. S., and Woolley, P. V.:Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy.Invest. New Drugs. 6, 243–246 (1988).PubMedCrossRefGoogle Scholar
  12. Plasse, T. F., Gorter, R. W., Krasnow, S. H., Lane, M., Shepard, K. V., and Wadleig, H. R. G.: Recent clinical experince with dronabinol.Pharmacol. Biochem. Behav. 40, 695–700 (1991).PubMedCrossRefGoogle Scholar
  13. Sallan, S. E., Cronin, C., Zelen, M., and Zinberg, N. E.: Antiemetics in patients receiving chemotherapy for cancer: A randomized comparison of δ-9-tetrahydrocannabinol and prochlorperazine.N. Engl. J. Med. 302, 135–138 (1980).PubMedGoogle Scholar

Copyright information

© The Pharmaceutical Society of Korea 1996

Personalised recommendations

 

This is a preview of subscription content, log in to check access.

Preview

BF02976895.pdf

References Cited

  • Baek, S. H., Yook, C. N. and Han, D. S.: Boron trifluoride etherate on alumina-A modified Lewis acid reagent(V). A convenient single step synthesis of cannabinoids.Bull. Kor. Chem. Soc. 16(3), 293–296 (1991).Google Scholar
  • Baek, S. H., Srebnik, M., and Mechoulam, R.: Boron trifluoride etherate on alumina-A modified Lewis acid reagent. An improved synthesis of cannabidiol.Tetrahedron Lett. 26(8), 1083–1086 (1985).CrossRefGoogle Scholar
  • Baik, K. U., and Ahn, B. Z.: Cyctotoxic activities of some geranylated flavones against L 1210 cell.J. Pharm. Soc. Korea, 32(2), 125–128 (1988).Google Scholar
  • colasanti, B. K., and Gong, H., Marihuana 87, Chesher, G.; Consroe, P.; Musty, R. Ed., Australian Government Publishing Service, Canberra, pp. 119–124 (1988).Google Scholar
  • Carmichael, J., Degraff, W. G., Gazdar, A. F., Minna, J. D., and Mitchell, J. B., Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing.Cancer Res. 47, 936–942 (1987).PubMedGoogle Scholar
  • Dewey, W. L.: Cannabinoid pharmacology.Pharmacol. Rev., 38, 151–178 (1986).PubMedGoogle Scholar
  • Kleinman, S., Weitzman, S. A., Cassem, N., and Andrews, E.: Double blind trial of δ-9-tetrahydrocannabinol (THC) as an adjunct to prochlorperazine for chemotherapy-induced vomiting.Curr. Ther. Res. 34, 1014–1017 (1983).Google Scholar
  • Kang, K. S., Ryu, S. H., and Ahn, B. Z.: Antineoplastic natural products and the analogues VI.Arch. Pharm. Res. 8, 187–190 (1985).CrossRefGoogle Scholar
  • Mechoulam, R.: In Cannabinoids as therapeutic agents, Boca Raton, CRC Press Inc., (1986).Google Scholar
  • Mosmann, T. J.:Rapid colorimetric assays for cellular growth and survival: application to proliferation and cytotoxicity assays.Immunol. Methods, 65, 55–63 (1983).CrossRefGoogle Scholar
  • McCabe, M., Smith, F. P., Macdonald, J. S., and Woolley, P. V.:Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy.Invest. New Drugs. 6, 243–246 (1988).PubMedCrossRefGoogle Scholar
  • Plasse, T. F., Gorter, R. W., Krasnow, S. H., Lane, M., Shepard, K. V., and Wadleig, H. R. G.: Recent clinical experince with dronabinol.Pharmacol. Biochem. Behav. 40, 695–700 (1991).PubMedCrossRefGoogle Scholar
  • Sallan, S. E., Cronin, C., Zelen, M., and Zinberg, N. E.: Antiemetics in patients receiving chemotherapy for cancer: A randomized comparison of δ-9-tetrahydrocannabinol and prochlorperazine.N. Engl. J. Med. 302, 135–138 (1980).PubMedGoogle Scholar

Copyright information

© The Pharmaceutical Society of Korea 1996

About this article

Cite this article as:

Baek, SH., Du Han, S., Yook, C.N. et al. Arch. Pharm. Res. (1996) 19: 228. https://doi.org/10.1007/BF02976895

  • Received 17 November 1995
    DOI https://doi.org/10.1007/BF02976895
    Publisher Name Pharmaceutical Society of Korea
    Print ISSN 0253-6269
    Online ISSN 1976-3786

Personalised recommendations

  1. Reciprocal relations between positive alcohol expectancies and peer use on adolescent drinking: An accelerated autoregressive cross-lagged model using the NCANDA sample
  2. Psychology of Addictive Behaviors 2018
  3. The Effect of Medical Marijuana Laws on Labor Market Outcomes
  4. The Journal of Law and Economics 2019
  5. Medical Marijuana Use in Older Adults
  6. Journal of the American Geriatrics Society 2018

 

Powered by:

Leave a Reply